Published in Transl Psychiatry on January 15, 2013
Amygdala and bed nucleus of the stria terminalis circuitry: Implications for addiction-related behaviors. Neuropharmacology (2013) 0.98
Serotonin engages an anxiety and fear-promoting circuit in the extended amygdala. Nature (2016) 0.93
The Human BNST: Functional Role in Anxiety and Addiction. Neuropsychopharmacology (2015) 0.88
Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry (2016) 0.86
Neuropeptide regulation of signaling and behavior in the BNST. Mol Cells (2014) 0.85
Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning. Pharmacol Biochem Behav (2015) 0.79
5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze. PLoS One (2013) 0.77
Evaluation of JNJ-54717793 a Novel Brain Penetrant Selective Orexin 1 Receptor Antagonist in Two Rat Models of Panic Attack Provocation. Front Pharmacol (2017) 0.75
5-HT2C receptors in the BNST are necessary for the enhancement of fear learning by selective serotonin reuptake inhibitors. Neurobiol Learn Mem (2016) 0.75
Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals. Eur J Psychotraumatol (2017) 0.75
Chronic fluoxetine dissociates contextual from auditory fear memory. Neurosci Lett (2016) 0.75
Emotion circuits in the brain. Annu Rev Neurosci (2000) 24.39
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav Neurosci (1992) 11.73
Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry (1990) 9.40
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci (2000) 9.12
Neuronal signalling of fear memory. Nat Rev Neurosci (2004) 7.03
The role of the amygdala in fear and anxiety. Annu Rev Neurosci (1992) 6.41
Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci (2002) 5.44
The amygdaloid complex: anatomy and physiology. Physiol Rev (2003) 5.22
Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology (2010) 5.07
Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ (2005) 4.74
Stress, memory and the amygdala. Nat Rev Neurosci (2009) 4.57
Cortical pathways to the mammalian amygdala. Prog Neurobiol (1998) 4.48
Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci (1988) 4.47
New vistas on amygdala networks in conditioned fear. J Neurophysiol (2004) 4.44
Encoding of conditioned fear in central amygdala inhibitory circuits. Nature (2010) 4.29
Amygdala inhibitory circuits and the control of fear memory. Neuron (2009) 4.16
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol (2003) 4.08
Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J Neurosci (2006) 3.92
Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science (2005) 2.91
The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J Neurosci (2008) 2.73
Spatial exploration-induced Arc mRNA and protein expression: evidence for selective, network-specific reactivation. J Neurosci (2005) 2.69
Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc Natl Acad Sci U S A (2003) 2.64
Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry (1994) 2.33
Lesions in the bed nucleus of the stria terminalis disrupt corticosterone and freezing responses elicited by a contextual but not by a specific cue-conditioned fear stimulus. Neuroscience (2004) 2.30
Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci (2003) 2.26
Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci (2003) 2.21
NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci (2002) 2.20
Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) (2007) 2.18
New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci (2011) 2.18
Mapping behaviorally relevant neural circuits with immediate-early gene expression. Curr Opin Neurobiol (2005) 2.16
Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci (2001) 2.10
Brain region-specific gene expression activation required for reconsolidation and extinction of contextual fear memory. J Neurosci (2009) 1.85
Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry (2003) 1.79
The activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) is required for memory consolidation of pavlovian fear conditioning in the lateral amygdala. J Neurosci (2008) 1.74
Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.73
The bed nucleus of the stria terminalis mediates inter-individual variations in anxiety and fear. J Neurosci (2009) 1.69
Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear. Behav Neurosci (2006) 1.67
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry (2004) 1.59
Thalamoamygdaloid projections in the rat: a test of the amygdala's role in sensory processing. J Comp Neurol (1991) 1.57
Discovering imaging endophenotypes for major depression. Mol Psychiatry (2011) 1.56
A cellular mechanism for targeting newly synthesized mRNAs to synaptic sites on dendrites. Proc Natl Acad Sci U S A (2001) 1.53
Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res (1997) 1.49
Central amygdala activity during fear conditioning. J Neurosci (2011) 1.44
The concepts of the ventral striatopallidal system and extended amygdala. Ann N Y Acad Sci (1999) 1.43
Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf (1999) 1.41
The effect of citalopram pretreatment on neuronal responses to neuropsychological tasks in normal volunteers: an FMRI study. Neuropsychopharmacology (2005) 1.38
A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study. Neuropsychopharmacology (2006) 1.37
The central nucleus of the amygdala is essential for acquiring and expressing conditional fear after overtraining. Learn Mem (2007) 1.37
Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry (2007) 1.36
Effector immediate-early gene arc in the amygdala plays a critical role in alcoholism. J Neurosci (2008) 1.32
Contextual conditioning and auditory cue conditioning dissociate during development. Behav Neurosci (1993) 1.31
Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci (1991) 1.27
Pretraining NMDA receptor blockade in the basolateral complex, but not the central nucleus, of the amygdala prevents savings of conditional fear. Behav Neurosci (2003) 1.27
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol (2001) 1.27
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) (1989) 1.23
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci (2003) 1.22
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety. Biol Psychiatry (1998) 1.19
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology (Berl) (1997) 1.16
Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) (2005) 1.14
Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry (1999) 1.11
Treating generalized anxiety disorder. J Clin Psychiatry (2003) 1.06
An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol (1987) 1.06
Learning-induced arg 3.1/arc mRNA expression in the mouse brain. Learn Mem (2003) 1.04
Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: an ethological analysis. Pharmacol Biochem Behav (2000) 1.03
The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.03
Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology (Berl) (1994) 1.03
Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis. Neuroscience (2008) 1.02
Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett (2005) 1.00
Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience (2009) 0.97
Associative structure of fear memory after basolateral amygdala lesions in rats. Behav Neurosci (2008) 0.92
Neurons of the bed nucleus of the stria terminalis (BNST). Electrophysiological properties and their response to serotonin. Ann N Y Acad Sci (1999) 0.91
Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. Neuropharmacology (2002) 0.91
Does the bed nucleus of the stria terminalis mediate fear behaviors? Behav Neurosci (1998) 0.91
Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression. Brain Res Bull (2001) 0.90
Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharmacology (2000) 0.90
Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor. Eur J Pharmacol (2006) 0.88
Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol (1993) 0.88
Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology (Berl) (1996) 0.87
Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex. Pharmacol Biochem Behav (1995) 0.87
Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats. Front Behav Neurosci (2011) 0.86
Extracellular serotonin level in the basolateral nucleus of the amygdala and dorsal periaqueductal gray under unconditioned and conditioned fear states: an in vivo microdialysis study. Brain Res (2009) 0.85
Effect of citalopram, a selective serotonin reuptake inhibitor, on the acquisition of conditioned freezing. Eur J Pharmacol (1996) 0.82
Patterns of c-fos expression induced by fluvoxamine are different after acute vs. chronic oral administration. Eur Neuropsychopharmacol (1998) 0.80
Fluoxetine and 8-OH-DPAT in the lateral septum enhances and impairs retention of an inhibitory avoidance response in rats. Physiol Behav (1992) 0.79
Involvement of the amygdala in the effect of antidepressants on the passive avoidance deficit in bulbectomised rats. Psychopharmacology (Berl) (1981) 0.77
Studies on plasmid replication. I. Plasmid incompatibility and establishment in Staphylococcus aureus. J Mol Biol (1972) 5.84
Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell (2001) 3.55
Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning. J Neurosci (2000) 2.64
Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem (2001) 2.31
Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxiety-like behavior. Neuroscience (2004) 2.14
Prolonged behavioral stress enhances synaptic connectivity in the basolateral amygdala. Neuroscience (2006) 1.66
Spatiotemporal development and distribution of intercellular junctions in adult rat cardiomyocytes in culture. Circ Res (1999) 1.66
L-type voltage-gated calcium channels mediate NMDA-independent associative long-term potentiation at thalamic input synapses to the amygdala. J Neurosci (1999) 1.42
Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients. Transplantation (2000) 1.42
Contrast-echocardiography: confirmation of patency of laser channels after transmyocardial laser revascularization. Eur J Echocardiogr (2002) 1.40
The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study. J Thorac Cardiovasc Surg (2000) 1.40
The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry (2009) 1.15
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. Mol Psychiatry (2012) 1.14
Stress-induced spine loss in the medial amygdala is mediated by tissue-plasminogen activator. Neuroscience (2006) 1.05
The diagnostic content of family practice: 50 most common diagnoses recorded in the WAMI community practices. J Fam Pract (1982) 1.05
2-Amino-3-phosphonopropionic acid, an inhibitor of glutamate-stimulated phosphoinositide turnover, blocks induction of homosynaptic long-term depression, but not potentiation, in rat hippocampus. Neurosci Lett (1991) 1.02
Epidemiology of occupational injuries and illnesses in a university population: a focus on age and gender differences. Am J Ind Med (2001) 0.98
Hypobaric hypoxia-induced dendritic atrophy of hippocampal neurons is associated with cognitive impairment in adult rats. Neuroscience (2007) 0.97
Acute and chronic effects of selective serotonin reuptake inhibitor treatment on fear conditioning: implications for underlying fear circuits. Neuroscience (2013) 0.89
Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala. Neuroscience (2009) 0.89
Novadaq Spy Intraoperative Imaging System--current status. Thorac Cardiovasc Surg (2003) 0.87
Midterm results after the Mini-Maze procedure. Eur J Cardiothorac Surg (1999) 0.86
Stress-induced changes in sleep and associated neuronal activity in rat hippocampus and amygdala. Neuroscience (2008) 0.84
Inflammatory aneurysm of the ascending aorta. Eur J Cardiothorac Surg (2001) 0.81
Pulmonary atresia with intact ventricular septum: results and predictive factors of surgical treatment. Thorac Cardiovasc Surg (1992) 0.81
Fatal fungal pericarditis after cardiac surgery and immunosuppression. J Thorac Cardiovasc Surg (1991) 0.80
[Symptomatic true aneurysm of a venous bypass with compression of the right atrium]. Z Kardiol (2000) 0.80
Reoperations after dacron patch aortoplasty with heparinized femoro-femoral bypass. Eur J Cardiothorac Surg (1997) 0.79
Do patients want minimally invasive aortic valve replacement? Eur J Cardiothorac Surg (2000) 0.78
Prophylactic treatment with ganciclovir for cytomegalovirus infection in heart transplantation. Transplant Proc (1991) 0.77
Thrombotic formations within the aortic arch as source of embolization in patients with coagulopathia. Eur J Cardiothorac Surg (2001) 0.75
[Papillary muscle rupture after mitral valve replacement with preservation of subvalvular structures]. Z Kardiol (2001) 0.75
[Early and late results after surgical treatment of pulmonary atresia with intact ventricular septum]. Helv Chir Acta (1991) 0.75
Images in cardio-thoracic surgery. Cardioscopic examination of left ventricular thrombus. Eur J Cardiothorac Surg (1997) 0.75
Cardioscopy: potential applications and benefit in cardiac surgery. Eur J Cardiothorac Surg (1999) 0.75
Pharmaceutical group purchasing cuts costs, expands knowledge. Hospitals (1976) 0.75
Leukocyte-depleted secondary blood cardioplegia attenuates reperfusion injury after myocardial ischemia. Thorac Cardiovasc Surg (2003) 0.75
Transmyocardial laser revascularisation has no beneficial effect on high energy phosphates and lactate content during acute myocardial ischaemia in pigs. Eur J Cardiothorac Surg (1999) 0.75
Peripheral arterial embolism originating from a thrombus in the ascending aorta. Thorac Cardiovasc Surg (2001) 0.75
Prophylactic cytolytic therapy in heart transplantation: monoclonal versus polyclonal antibody therapy. J Heart Lung Transplant (1992) 0.75
Pre- and postoperative assessment of left ventricular function by magnetic resonance imaging and 2-D-echocardiography in patients undergoing left ventricular aneurysmectomy. Thorac Cardiovasc Surg (2004) 0.75
Symptomatic aneurysm of a saphenous vein graft with compression of the right atrium. Heart Surg Forum (1999) 0.75
Identifying stressors is necessary to combat potential health problems. Occup Health Saf (1989) 0.75
[Single cusp homograft implantation in the reconstruction of right ventricular outflow tract in the correction of tetralogy of Fallot]. Schweiz Med Wochenschr (1992) 0.75
Thrombus formation of the right heart. Eur J Cardiothorac Surg (1998) 0.75
Repair of an aneurysm of the pulmonary trunk in a 65-year-old patient. Ann Thorac Surg (1999) 0.75
Single leukocyte filter (Pall BC1B) fails in multidose cold blood cardioplegia. J Thorac Cardiovasc Surg (1997) 0.75
[The maze operation--surgical therapy of chronic atrial fibrillation: modification to mini-maze operation]. Z Kardiol (2000) 0.75
Pericarditis constrictiva after aortic valve replacement simulating tricuspid stenosis. Eur J Cardiothorac Surg (1992) 0.75
Postoperative fever, hypotension, and renal failure. J Tenn Med Assoc (1991) 0.75
Ruptured papillary muscle after mitral valve replacement with preservation of chordae tendineae. Ann Thorac Surg (2001) 0.75